SCHEMBL19797701

SCHEMBL19797701

c1ccc(-n2c3ccccc3c3c2ccc2c4ccc(-n5c6ccccc6c6ccccc65)cc4n(-c4ccc5c6ccccc6c6ccccc6c5c4)c23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ATM Q13315 1/20 0.50
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
MAPK1 P28482 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
BRCA1 P38398 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PTPN1 P18031 2/20 0.32
MAT2A P31153 1/20 0.32
HDAC4 P56524 1/20 0.32
MAPK8 P45983 2/20 0.31
IL1R1 P14778 1/20 0.31
KDR P35968 1/20 0.31
MAPK9 P45984 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27044590 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL27044609 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL16076377 0.97 L3MBTL1 (0.53) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL16076348 0.97 L3MBTL1 (0.53) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL18086298 0.97 L3MBTL1 (0.53) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL24531877 0.96 L3MBTL1 (0.51) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL26472280 0.96 L3MBTL1 (0.51) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL26472338 0.96 L3MBTL1 (0.51) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL26472340 0.96 L3MBTL1 (0.51) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL26809304 0.96 L3MBTL1 (0.51) L3MBTL1KDM4EATMJAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10505126-B2 Composition for organic optoelectric device and organic optoelectric device and display device SAMSUNG SDI CO., LTD. (KR) 2019-12-10 US disclosed
US-10319921-B2 Composition for organic optoelectronic device and organic optoelectronic device and display device SAMSUNG SDI CO., LTD. (KR) 2019-06-11 US disclosed
US-20180026205-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-01-25 US disclosed
US-20180026205-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-01-25 US disclosed
US-20180026204-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-01-25 US disclosed
US-20180026204-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10319921-B2 Composition for organic optoelectronic device and organic optoelectronic device and display device OR10J3, OR51E2, OXER1 L3MBTL1 4789/4885KDM4E 4585/4885ATM 4359/4885
US-10505126-B2 Composition for organic optoelectric device and organic optoelectric device and display device OXER1, OR10J3, OR51E2 L3MBTL1 4812/4885KDM4E 4531/4885ATM 4381/4885
US-20180026204-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OR10J3, OR51E2 L3MBTL1 4812/4885KDM4E 4531/4885ATM 4381/4885
US-20180026205-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OR51E2, OXER1 L3MBTL1 4794/4885KDM4E 4452/4885ATM 4365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.